Trypanosoma cruzi

The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives

Viability study of a multiplex diagnostic platform for Chagas disease

Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations

Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?

Trypanosoma cruzi: ancestral genomes and population structure

Molecular mechanisms of Trypanosoma cruzi infection by oral route

Structural organization of Trypanosoma cruzi

A century of research: what have we learned about the interaction of Trypanosoma cruzi with host cells?

Paleoparasitology of Chagas disease: a review

A new approach for potential drug target discovery through in silico metabolic pathway analysis using Trypanosoma cruzi genome information

Absence of Fas-L aggravates renal injury in acute Trypanosoma cruzi infection

Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection

Trypanosoma cruzi: parasite antigens sequestered in heart interstitial dendritic cells are related to persisting myocarditis in benznidazole-treated mice

In vitro activity of thienyl-2-nitropropene compounds against Trypanosoma cruzi

Serological diagnosis of Chagas disease: evaluation and characterisation of a low cost antigen with high sensitivity and specificity

Performance levels of four Latin American laboratories for the serodiagnosis of Chagas disease in Mexican sera samples

Molecular and biochemical characterisation of Trypanosoma cruzi phosphofructokinase

Immunological imbalance between IFN-³ and IL-10 levels in the sera of patients with the cardiac form of Chagas disease

Developmental and reproductive patterns of Triatoma brasiliensis infected with Trypanosoma cruzi under laboratory conditions

In vitro effects of citral on Trypanosoma cruzi metacyclogenesis

Differential tissue tropism of Trypanosoma cruzi strains: an in vitro study

The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice

Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection

Sylvatic foci of the Chagas disease vector Triatoma infestans in Chile: description of a new focus and challenges for control programs

Immune homeostasis to microorganisms in the guts of triatomines (Reduviidae): a review

The biological in vitro effect and selectivity of aromatic dicationic compounds on Trypanosoma cruzi

In vitro and in vivo experimental models for drug screening and development for Chagas disease

Chemical composition and antiprotozoal activities of Colombian Lippia spp essential oils and their major components

15d-PGJ2 modulates acute immune responses to Trypanosoma cruzi infection

The activity of a metronidazole analogue and its β-cyclodextrin complex against Trypanosoma cruzi

Trypanosoma cruzi trypomastigotes induce cytoskeleton modifications during HeLa cell invasion

Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy

Regulatory elements involved in the post-transcriptional control of stage-specific gene expression in Trypanosoma cruzi: a review

Studying nanotoxic effects of CdTe quantum dots in Trypanosoma cruzi

New insights into trypanosomatid U5 small nuclear ribonucleoproteins

Trypanosoma cruzi: parasite persistence in tissues in chronic chagasic Brazilian patients

Characterization of TcSTI-1, a homologue of stress-induced protein-1, in Trypanosoma cruzi

Vaccination with Trypanosoma rangeli modulates the profiles of immunoglobulins and IL-6 at local and systemic levels in the early phase of Trypanosoma cruzi experimental infection

Differential in vitro activity of the DNA topoisomerase inhibitor idarubicin against Trypanosoma rangeli and Trypanosoma cruzi

Distinct subcellular localization of tRNA-derived fragments in the infective metacyclic forms of Trypanosoma cruzi

The zinc finger protein TcZFP2 binds target mRNAs enriched during Trypanosoma cruzi metacyclogenesis

Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease

The level of ascorbate peroxidase is enhanced in benznidazole-resistant populations of Trypanosoma cruzi and its expression is modulated by stress generated by hydrogen peroxide

Acute experimental Trypanosoma cruzi infection: establishing a murine model that utilises non-invasive measurements of disease parameters

Chagas disease: control, elimination and eradication. Is it
possible?

Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic setting

A new survey of the serology of human Trypanosoma cruziinfection in the Rio Negro microregion, Brazilian Amazon: a critical analysis

A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention

Fibronectin modulates thymocyte-thymic epithelial cell interactions following Trypanosoma cruzi infection

Effect of treatment with cyclophosphamide in low doses upon
the onset of delayed type hypersensitivity in mice chronically infected with
Trypanosoma cruzi: involvement of heart interstitial dendritic
cells

Inscrever-se em Trypanosoma cruzi